메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 27, Issue 34, 2009, Pages
Geographic distribution of lapatinib-induced skin rash: Sparing of abdominal skin persists in the transverse rectus abdominis myocutaneous flap
Author keywords

[No Author keywords available]
Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; LAPATINIB; METHOTREXATE; ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; QUINAZOLINE DERIVATIVE;
EID: 73349116875     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.22.7868     Document Type: Article
Times cited : (2)
References (7)
  • 1
    • 33748935930 scopus 로고    scopus 로고
    • Dermatologic side effects associated with the epidermal growth factor receptor inhibitors
    • Agero ALC, Dusza SW, Benvenuto-Andrade C, et al: Dermatologic side effects associated with the epidermal growth factor receptor inhibitors. J Am Acad Dermatol 55:657-670, 2006
    • (2006) J Am Acad Dermatol , vol.55 , pp. 657-670
    • Agero, A.L.C.1    Dusza, S.W.2    Benvenuto-Andrade, C.3
  • 2
    • 61449090567 scopus 로고    scopus 로고
    • Analysis of dermatologic events in patients with cancer treated with lapatinib
    • Lacouture ME, Laabs SM, Koehler M, et al: Analysis of dermatologic events in patients with cancer treated with lapatinib. Breast Cancer Res Treat 114:485-493, 2008
    • (2008) Breast Cancer Res Treat , vol.114 , pp. 485-493
    • Lacouture, M.E.1    Laabs, S.M.2    Koehler, M.3
  • 3
    • 0021135608 scopus 로고
    • Comparison of epidermal growth factor binding and receptor distribution in normal human epidermis and epidermal appendages
    • Nanney LB, Magid M, Stoscheck CM, et al: Comparison of epidermal growth factor binding and receptor distribution in normal human epidermis and epidermal appendages. J Invest Dermatol 83:385-393, 1984
    • (1984) J Invest Dermatol , vol.83 , pp. 385-393
    • Nanney, L.B.1    Magid, M.2    Stoscheck, C.M.3
  • 4
    • 0030977565 scopus 로고    scopus 로고
    • Genetically null mice reveal a central role for epidermal growth factor receptor in the differentiation of the hair follicle and normal hair development
    • Hansen LA, Alexander N, Hogan ME, et al: Genetically null mice reveal a central role for epidermal growth factor receptor in the differentiation of the hair follicle and normal hair development. Am J Path 150:1959-1975, 1997
    • (1997) Am J Path , vol.150 , pp. 1959-1975
    • Hansen, L.A.1    Alexander, N.2    Hogan, M.E.3
  • 5
    • 0036051312 scopus 로고    scopus 로고
    • Follicular and epidermal alterations in patients treated with ZK1839 (Iressa), an inhibitor of the epidermal growth factor receptor
    • Van Doorn R, Kirtschig G, Scheffer E, et al: Follicular and epidermal alterations in patients treated with ZK1839 (Iressa), an inhibitor of the epidermal growth factor receptor. Br J Dermatology 147:598-601, 2002
    • (2002) Br J Dermatology , vol.147 , pp. 598-601
    • Van Doorn, R.1    Kirtschig, G.2    Scheffer, E.3
  • 6
    • 33745001242 scopus 로고    scopus 로고
    • Erlotinib induced skin rash spares skin in previous radiotherapy field
    • Mitra SS, Simcock R: Erlotinib induced skin rash spares skin in previous radiotherapy field. J Clin Oncol 24:28e-29e, 2006
    • (2006) J Clin Oncol , vol.24
    • Mitra, S.S.1    Simcock, R.2
  • 7
    • 34548222618 scopus 로고    scopus 로고
    • Lapatinib-associated toxicity and practical management recommendations
    • Moy B, Goss PE: Lapatinib-associated toxicity and practical management recommendations. The Oncologist 12:756-765, 2007
    • (2007) The Oncologist , vol.12 , pp. 756-765
    • Moy, B.1    Goss, P.E.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.